Inhibition of oxidative stress in rostral ventrolateral medulla improves impaired baroreflex sensitivity in stroke-prone spontaneously hypertensive rats

International Heart Journal

Volumn 53, Issue 3, 2012, Pages 193-198

  Ogawa, Kiyohiro ^a   Hirooka, Yoshitaka ^a   Shinohara, Keisuke ^a   Kishi, Takuya ^a   Sunagawa, Kenji ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Baroreflex sensitivity; Brain; Hypertension; Reactive oxygen species; Sympathetic nervous system

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; MANGANESE SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADRENERGIC ACTIVITY; ADRENERGIC RECEPTOR BLOCKING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BRAIN STEM; CONTROLLED STUDY; DRUG MECHANISM; ESSENTIAL HYPERTENSION; GENE OVEREXPRESSION; HEART RATE; IN VIVO STUDY; MALE; NONHUMAN; NORADRENALIN URINE LEVEL; OXIDATIVE STRESS; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RAT; ROSTRAL VENTROLATERAL MEDULLA; SENSITIVITY ANALYSIS; STRAIN DIFFERENCE; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; THALAMUS VENTRAL NUCLEUS; VIRAL GENE DELIVERY SYSTEM; WISTAR KYOTO RAT;

ANIMALS; ATROPINE; BAROREFLEX; BETA-GALACTOSIDASE; BLOOD PRESSURE; GENE TRANSFER TECHNIQUES; HEART RATE; HUMANS; HYPERTENSION; MALE; MEDULLA OBLONGATA; OXIDATIVE STRESS; PARASYMPATHOLYTICS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; REACTIVE OXYGEN SPECIES; STROKE; SUPEROXIDE DISMUTASE; SYMPATHETIC NERVOUS SYSTEM; TRANSFECTION;

EID: 84863439676     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.53.193     Document Type: Article

References (43)

1. Dampney RA. Functional organization of central pathways regulating the cardiovascular system. Physiol Rev 1994; 74: 323-64. (Review)
2. Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci 2006; 7: 335-46. (Review)
3. Mancia G, Ludbrook J, Ferrari A, Gregorini L, Zanchetti A. Baroreceptor reflexes in human hypertension. Circ Res 1978; 43: 170-7.
4. Parati G, Di Rienzo M, Bertinieri G, et al. Evaluation of the baroreceptor-heart rate reflex by 24-hour intra-arterial blood pressure monitoring in humans. Hypertension 1988; 12: 214-22.
5. Kishi T, Hirooka Y, Kimura Y, et al. Overexpression of eNOS in RVLM improves impaired baroreflex control of heart rate in SHRSP. Rostral ventrolateral medulla. Stroke-prone spontaneously hypertensive rats. Hypertension 2003; 41: 255-60.
6. Hesse C, Charkoudian N, Liu Z, Joyner MJ, Eisenach JH. Baroreflex sensitivity inversely correlates with ambulatory blood pressure in healthy normotensive humans. Hypertension 2007; 50: 41-6.
7. Davies LC, Francis D, Jurak P, Kara T, Piepoli M, Coats AJ. Reproducibility of methods for assessing baroreflex sensitivity in normal controls and in patients with chronic heart failure. Clin Sci (Lond) 1999; 97: 515-22.
8. Mortara A, La Rovere MT, Pinna GD, et al. Arterial baroreflex modulation of heart rate in chronic heart failure: clinical and hemodynamic correlates and prognostic implications. Circulation 1997; 96: 3450-8.
9. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998; 351: 478-84.
10. Shan ZZ, Dai SM, Su DF. Relationship between baroreceptor reflex function and end-organ damage in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 1999; 277: H1200-6.
11. Miao CY, Su DF. The importance of blood pressure variability in rat aortic and left ventricular hypertrophy produced by sinoaortic denervation. J Hypertens 2002; 20: 1865-72.
12. Tatasciore A, Renda G, Zimarino M, et al. Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects. Hypertension 2007; 50: 325-32.
13. Billman GE, Schwartz PJ, Stone HL. Baroreceptor reflex control of heart rate: a predictor of sudden cardiac death. Circulation 1982; 66: 874-80.
14. Smyth HS, Sleight P, Pickering GW. Reflex regulation of arterial pressure during sleep in man. A quantitative method of assessing baroreflex sensitivity. Circ Res 1969; 24: 109-21.
15. Parlow J, Viale JP, Annat G, Hughson R, Quintin L. Spontaneous cardiac baroreflex in humans. Comparison with drug-induced responses. Hypertension 1995; 25: 1058-68.
16. Kishi T, Hirooka Y, Kimura Y, Ito K, Shimokawa H, Takeshita A. Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation 2004; 109: 2357-62.
17. Kishi T, Hirooka Y, Konno S, Sunagawa K. Atorvastatin improves the impaired baroreflex sensitivity via anti-oxidant effect in the rostral ventrolateral medulla of SHRSP. Clin Exp Hypertens 2009; 31: 698-704.
18. Kishi T, Hirooka Y, Sakai K, Shigematsu H, Shimokawa H, Takeshita A. Overexpression of eNOS in the RVLM causes hypotension and bradycardia via GABA release. Hypertension 2001; 38: 896-901.
19. Sakai K, Hirooka Y, Matsuo I, et al. Overexpression of eNOS in NTS causes hypotension and bradycardia in vivo. Hypertension 2000; 36: 1023-8.
20. Hirooka Y, Sakai K, Kishi T, Takeshita A. Adenovirus-mediated gene transfer into the NTS in conscious rats. A new approach to examining the central control of cardiovascular regulation. Ann N Y Acad Sci 2001; 940: 197-205.
21. Zwacka RM, Zhou W, Zhang Y, et al. Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-kappaB activation. Nat Med 1998; 4: 698-704.
22. Kishi T, Hirooka Y, Konno S, Ogawa K, Sunagawa K. Angiotensin II type 1 receptor-activated caspase-3 through ras/mitogen-activated protein kinase/extracellular signal-regulated kinase in the rostral ventrolateral medulla is involved in sympathoexcitation in stroke-prone spontaneously hypertensive rats. Hypertension 2010; 55: 291-7.
23. Kishi T, Hirooka Y, Ito K, Sakai K, Shimokawa H, Takeshita A. Cardiovascular effects of overexpression of endothelial nitric oxide synthase in the rostral ventrolateral medulla in stroke-prone spontaneously hypertensive rats. Hypertension 2002; 39: 264-8.
24. Gao L, Wang W, Li YL, et al. Sympathoexcitation by central ANG II: roles for AT1 receptor upregulation and NAD(P)H oxidase in RVLM. Am J Physiol Heart Circ Physiol 2005; 288: H2271-9.
25. Gao L, Wang W, Li YL, et al. Simvastatin therapy normalizes sympathetic neural control in experimental heart failure: roles of angiotensin II type 1 receptors and NAD(P)H oxidase. Circulation 2005; 112: 1763-70.
26. Pan YX, Gao L, Wang WZ, et al. Exercise training prevents arterial baroreflex dysfunction in rats treated with central angiotensin II. Hypertension 2007; 49: 519-27.
27. Lohmeier TE, Irwin ED, Rossing MA, Serdar DJ, Kieval RS. Prolonged activation of the baroreflex produces sustained hypotension. Hypertension 2004; 43: 306-11.
28. Heusser K, Tank J, Engeli S, et al. Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension 2010; 55: 619-26.
29. Ormezzano O, Cracowski JL, Quesada JL, Pierre H, Mallion JM, Baguet JP. EVAluation of the prognostic value of BARoreflex sensitivity in hypertensive patients: the EVABAR study. J Hypertens 2008; 26: 1373-8.
30. Katsube Y, Saro H, Naka M, et al. Decreased baroreflex sensitivity in patients with stable coronary artery disease is correlated with the severity of coronary narrowing. Am J Cardiol 1996; 78: 1007-10.
31. Somers V, Dyken ME, Mark AL, Abboud FM. Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med 1993; 328: 303-7.
32. Munakata M, Aihara A, Nunokawa T, et al. The influence of oneyear treatment by angiotensin converting enzyme inhibitor on baroreflex sensitivity and flow-mediated vasodilation of the brachial artery in essential hypertension--comparison with calcium channel blockers. Clin Exp Hypertens 2003; 25: 169-81.
33. Kishi T, Hirooka Y, Konno S, Sunagawa K. Cilnidipine inhibits the sympathetic nerve activity and improves baroreflex sensitivity in patients with hypertension. Clin Exp Hypertens 2009; 31: 241-9.
34. Lindqvist M, Kahan T, Melcher A, Ekholm M, Hjemdahl P. Longterm calcium antagonist treatment of human hypertension with mibefradil or amlodipine increases sympathetic nerve activity. Hypertens 2007; 25: 169-75.
35. Konno S, Hirooka Y, Araki S, Koga Y, Kishi T, Sunagawa K. Azelnidipine decreases sympathetic nerve activity via antioxidant effect in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats. J Cardiovasc Pharmacol 2008; 52: 555-60.
36. Gao L, Wang W, Liu D, Zucker IH. Exercise training normalizes sympathetic outflow by central antioxidant mechanisms in rabbitswith pacing-induced chronic heart failure. Circulation 2007; 115: 3095-102
37. Zimmerman MC, Lazartigues E, Sharma RV, Davisson RL. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res 2004; 95: 210-6.
38. Oliveira-Sales EB, Nishi EE, Carillo BA, et al. Oxidative stress in the sympathetic premotor neurons contributes to sympathetic activation in renovascular hypertension. Am J Hypertens 2009; 22: 484-92.
39. Fujita M, Ando K, Nagae A, Fujita T. Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in salt-sensitive hypertension. Hypertension 2007; 50: 360-7.
40. Oliveira-Sales EB, Dugaich AP, Carillo BA, et al. Oxidative stress contributes to renovascular hypertension. Am J Hypertens 2008; 21: 98-104.
41. Gao SA, Johansson M, Rundqvist B, Lambert G, Jensen G, Friberg P. Reduced spontaneous baroreceptor sensitivity in patients with renovascular hypertension. J Hypertens 2002; 20: 111-6.
42. Mussalo H, Vanninen E, Ikäheimo R, et al. Baroreflex sensitivity in essential and secondary hypertension. Clin Auton Res 2002; 12: 465-71.
43. Nishihara M, Hirooka Y, Matsukawa R. Kishi T, Sunagawa K. Oxidative stress in the rostral ventrolateral medulla modulates excitatory and inhibitory inputs in spontaneously hypertensive rats. J Hypertens 2012; 30: 97-106.